C. Cimarelli et al. / Tetrahedron: Asymmetry 13 (2002) 2417–2426
2423
cm−1; 1H NMR (300 MHz, CDCl3): l 1.49 (d, 3H,
J=6.8 Hz), 2.52 (br s, 1H), 3.74 (s, 3H), 3.89 (br s, 1H),
5.86 (s, 1H), 6.60–7.80 (m, 15H), 13.80 (br s, 1H); 13C
NMR (75 MHz, CDCl3): l 22.9, 54.8, 55.5, 57.3, 110.8,
113.5, 120.4, 121.5, 121.8, 122.9, 126.8, 127.8, 128.1,
128.6, 128.8, 129.1, 129.5, 129.7, 129.9, 130.1, 133.2,
143.3, 157.0, 158.5. Anal. calcd for C26H25NO2 (383.5):
C, 81.43; H, 6.57; N, 3.65. Found: C, 81.60; H, 6.63; N,
3.60%.
C25H23NO2 (369.5): C, 81.27; H, 6.27; N, 3.79. Found:
C, 81.34; H, 6.15; N, 3.61%.
4.2.12. 1-[(R)-Phenyl{[(1%R)-2-hydroxy-1%-phenylethyl]-
amino}methyl]-2-naphthol, (R,R)-3f. Oil; [h]2D0=−179.3
(c 1.3, CHCl3); IR (liquid film): wmax 3307, 1620, 1603,
1268, 1237, 735, 700 cm−1; 1H NMR (300 MHz,
CDCl3): l 3.78–4.00 (m, 2H), 4.05–4.10 (m, 1H), 4.50–
6.30 (br s, 3H), 5.91 (s, 1H), 7.15–7.75 (m, 16H); 13C
NMR (75 MHz, CDCl3): l 61.0, 62.0, 65.0, 114.9,
120.7, 121.6, 122.9, 127.0, 127.7, 128.4, 128.5, 129.1,
129.2, 129.3, 129.5, 129.7, 130.2, 132.8, 139.4, 141.5,
157.0. Anal. calcd for C25H23NO2 (369.5): C, 81.27, H
6.27, N 3.79. Found: C, 81.33; H, 6.21; N, 3.89%.
4.2.8. 1-[(R)-(2-Methoxyphenyl){[(1%R)-1%-phenylethyl]-
amino}methyl]-2-naphthol, (R,R)-3d. White crystals; mp
151–155°C (EtOH); [h]2D0=+213.2 (c 2.2, CHCl3); IR
(Nujol): wmax 3293, 1620, 1600, 1243, 1095, 1028, 740
cm−1; 1H NMR (300 MHz, CDCl3): l 1.64 (d, 3H,
J=6.6 Hz), 2.30 (br s, 1H), 4.00 (q, 1H, J=6.6 Hz),
4.04 (s, 3H), 6.42 (s, 1H), 6.70–7.80 (m, 15H), 13.50 (br
s, 1H); 13C NMR (75 MHz, CDCl3): l 20.1, 54.1, 55.5,
55.8, 110.4, 113.1, 120.1, 121.2, 121.3, 122.3, 126.4,
126.5, 126.7, 127.2, 128.3, 128.5, 128.6, 128.7, 129.3,
129.5, 132.8, 143.8, 156.4, 157.8. Anal. calcd for
C26H25NO2 (383.5): C, 81.43; H, 6.57; N, 3.65. Found:
C, 81.50; H, 6.49; N, 3.57%.
4.2.13. 1-[(R)-Phenyl{[(1%R)-1%-(1-naphthyl)ethyl]amino}-
methyl]-2-naphthol, (R,R)-3g. White crystals; mp 159–
162°C (CH2Cl2–hexane); [h]2D0=−288.1 (c 1.0, CHCl3);
IR (Nujol): wmax 3320, 1621, 1589, 1270, 1237, 779, 744
cm−1; 1H NMR (300 MHz, CDCl3): l 1.65 (d, 3H,
J=6.6 Hz), 2.61 (br s, 1H), 4.90 (m, 1H), 5.51 (s, 1H),
7.00–7.95 (m, 18H), 13.95 (br s, 1H); 13C NMR (75
MHz, CDCl3): l 23.1, 51.3, 61.2, 113.5, 120.1, 121.2,
122.3, 122.5, 125.3, 125.6, 125.7, 125.8, 126.2, 126.3,
127.7, 128.0, 128.2, 128.3, 128.6, 128.7, 128.9, 129.1,
129.8, 132.1, 132.6, 141.6, 157.2. Anal. calcd for
C29H25NO (403.5): C, 86.32; H, 6.24; N, 3.47. Found:
C, 86.47; H, 6.29; N, 3.33%.
4.2.9.
1-[(S)-(2,3,4,5,6-Pentafluorophenyl){[(1%R)-1%-
phenylethyl]amino}methyl]-2-naphthol,
(1S,1%R)-3e.
White crystals; mp 159–163°C (CH2Cl2–hexane); [h]2D0=
−251.0 (c 1.1, CHCl3); IR (Nujol): wmax 3292, 1653,
1624, 1602, 1274, 1237, 820, 745, 701 cm−1; H NMR
1
(300 MHz, CDCl3): l 1.57 (d, 3H, J=6.6 Hz), 2.15 (br
s, 1H), 3.99 (m, 1H), 5.91 (s, 1H), 7.10–7.80 (m, 11H),
13.05 (br s, 1H); 13C NMR (75 MHz, CDCl3): l 22.8,
50.6, 57.0, 108.6, 115.2 (m), 119.7, 120.2, 122.5, 126.5,
127.0, 128.2, 128.6, 129.0, 129.1, 130.5, 132.2, 137.6
(dm, J=247.6), 141.0 (dm, J=248.8), 141.9, 145.03
(dm, J=252.0), 158.1. Anal. calcd for C25H18F5NO
(443.4): C, 67.72; H, 4.09; N, 3.16. Found: C, 67.90; H,
4.15; N, 3.12%.
4.2.14. 1-[(S)-Phenyl{[(1%R)-1%-(1-naphthyl)ethyl]amino}-
1
methyl]-2-naphthol, (1S,1%R)-3g. H NMR (300 MHz,
CDCl3): l 1.70 (d, 3H, J=6.6 Hz), 2.00 (br s, 1H), 4.89
(m, 1H), 5.99 (s, 1H), 7.00–8.00 (m, 18H), 13.30 (br s,
1H).
4.2.15. 1-[(1R)-2-Methyl-1-{[(1%R)-1%-(1-naphthyl)ethyl]-
amino}propyl]-2-naphthol, (R,R)-3h. White crystals; mp
147–150°C (hexane); [h]2D0=−193.1 (c 0.9, CHCl3); IR
(Nujol): wmax 3326, 2962, 1621, 1599, 1270, 1236, 778,
1
4.2.10.
1-[(R)-(2,3,4,5,6-Pentafluorophenyl){[(1%R)-1%-
745 cm−1; H NMR (300 MHz, CDCl3): l 0.76 (d, 3H,
phenylethyl]amino}methyl]-2-naphthol, (R,R)-3e. White
crystals; mp 142–144°C (CH2Cl2–hexane); [h]2D0=+226.4
(c 1.0, CHCl3); IR (Nujol): wmax 3301, 1652, 1624, 1522,
J=7.0 Hz), 0.99 (d, 3H, J=6.6 Hz), 1.62 (d, 3H, J=6.6
Hz), 2.07–2.32 (m, 1H), 2.52 (br s, 1H), 4.21 (d, 1H,
J=5.9 Hz), 4.68 (br s, 1H), 7.00–7.95 (m, 13H), 13.40
(br s, 1H); 13C NMR (75 MHz, CDCl3): l 18.3, 20.4,
23.4, 32.9, 50.2, 61.7, 115.2, 119.9, 121.8, 122.2, 122.7,
125.7, 125.9, 126.0, 126.3, 128.1, 128.7, 128.8, 128.9,
129.0, 129.3, 131.6, 133.5, 134.0, 140.3, 156.9. Anal.
calcd for C26H27NO (369.5): C, 84.51; H, 7.37; N, 3.79.
Found: C, 84.37; H, 7.45; N, 3.86%.
1
1275, 1236, 820, 747, 701 cm−1; H NMR (300 MHz,
CDCl3): l 1.63 (d, 3H, J=6.6 Hz), 2.15 (br s, 1H), 4.04
(q, 1H, J=6.6), 6.29 (s, 1H), 7.05–7.80 (m, 11H), 12.60
(br s, 1H); 13C NMR (75 MHz, CDCl3): l 21.6, 51.0,
56.3, 109.6, 115.5 (tm, J=16.5), 120.0, 120.7, 122.7,
126.6, 127.2, 128.1, 128.7, 129.1, 129.3, 130.7, 132.2,
140.0 (dm, J=253.1), 141.2 (dm, J=253.7), 142.4,
142.9 (dm, J=249.2), 157.8. Anal. calcd for
C25H18F5NO (443.4): C, 67.72; H, 4.09; N, 3.16. Found:
C, 67.88; H, 4.01; N, 3.09%.
4.2.16. 1-[(1S)-2-Methyl-1-{[(1%R)-1%-(1-naphthyl)ethyl]-
amino}propyl]-2-naphthol, (1S,1%R)-3h. 1H NMR (300
MHz, CDCl3): l 0.89 (d, 3H, J=7.0 Hz), 1.11 (d, 3H,
J=6.6 Hz), 1.64 (d, 3H, J=6.6 Hz), 2.15–2.50 (m, 2H),
4.75 (q, 1H, J=6.6 Hz), 4.81 (d, 1H, J=6.2 Hz),
7.00–8.00 (m, 13H), 12.80 (br s, 1H).
4.2.11. 1-[(S)-Phenyl{[(1%R)-2-hydroxy-1%-phenylethyl]-
amino}methyl]-2-naphthol, (1S,1%R)-3f. Oil; [h]2D0=
+139.4 (c 2.9, CHCl3); IR (liquid film): wmax 3309, 1622,
1
1601, 1269, 1236, 736, 699 cm−1; H NMR (300 MHz,
4.2.17. 1-[(1R)-Cyclohexyl{[(1%R)-1%-(1-naphthyl)ethyl]-
amino}methyl]-2-naphthol, (R,R)-3i. White crystals;
mp 155–158°C (CH2Cl2); [h]2D0=−227.5 (c 1.03,
CHCl3); IR (Nujol): wmax 3337, 2923, 1619, 1597, 1578,
1269, 1235, 780, 749 cm−1; 1H NMR (300 MHz,
CDCl3): l 0.90–1.35 (m, 6H), 1.50–1.97 (m, 5H), 1.60
CDCl3): l 3.78–4.00 (m, 3H), 4.50–6.30 (br s, 3H), 5.55
(s, 1H), 7.15–7.75 (m, 16H); 13C NMR (75 MHz,
CDCl3): l 60.5, 63.0, 66.8, 113.6, 120.5, 121.6, 123.0,
127.0, 128.1, 128.2, 128.6, 128.9, 129.0, 129.1, 129.3,
129.6, 130.4, 133.1, 139.4, 141.6, 157.2. Anal. calcd for